跳至主要内容
临床试验/DRKS00026646
DRKS00026646尚未招募不适用

Identification of Biological and Psychosocial Factors of Symptom Persistence in Pruritus - SOMACROSS-Pruritus-4

Kompetenzzentrum Chronischer Pruritus, Klinik für Hautkrankheiten, Universitätsklinikum Münster0 个研究点目标入组 200 人开始时间: 2021年9月17日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Age = 18 years
  • Group 1: Acute atopic dermatits (aAD)
  • acute eczema = 4 weeks at baseline
  • previous eczema free interval for at least 6 months
  • pruritus intensity (NRS worst pruritus of the last 24h): =5/10
  • Group 2: chronic atopic dermatitis (cAD)
  • clinical diagnosis of atopic dermatitis, for at least 6 months
  • chronic pruritus (= 6 weeks duration)
  • pruritus intensity (NRS worst pruritus of the last 24h): =5/10
  • Group 3: chronic pruritus on non-lesional skin (CPNL)
  • pruritus on non-lesional skin (absence of a dermatosis or scratch lesions)
  • chronic pruritus (= 6 weeks duration)
  • pruritus intensity (NRS worst pruritus of the last 24h): =5/10
  • Group 4: healthy controls
  • non-lesional skin (absence of a dermatosis or scratch lesions)
  • no pruritus (pruritus intensity NRS worst pruritus of the last 24h: 0/10)
  • no history of atopic dermatitis, allergic asthma, type 1 allergies
  • no chronic pain syndrome or intake of analgesic drugs

排除标准

  • - Acute exacerbation of a dermatosis (exception: atopic dermatitis) or cutaneous infection
  • - pregnancy, breastfeeding
  • - drug or alcohol abuse
  • - allergy against local anesthetics
  • - Tendency of developing keloids
  • - Chronic pain, fibromyalgia
  • - Intake of antihistamines, systemic steroids, systemic immunosuppressants, gabapentinoids or analgesics in the previous 4 weeks (intake of antidepressants is allowed if not as antipruritic medication).

研究者

发起方
Kompetenzzentrum Chronischer Pruritus, Klinik für Hautkrankheiten, Universitätsklinikum Münster

相似试验